Hospital News and Research

RSS

Cerus' INTERCEPT platelets therapeutically effective even after seven days of storage

Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.

18 Jan 2010

Results show neoadjuvant chemoradiotherapy improves patients with EC

Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.

18 Jan 2010

Scientists discover new links between inherited blindness and AHI1 gene

An international team of scientists, led by researchers at the University of California, San Diego School of Medicine have discovered new links between a common form of inherited blindness affecting children and a gene known as Abelson helper integration site-1 (AHI1).

18 Jan 2010

AVIR Green Hills Biotechnology commences deltaFLU Phase II study

AVIR Green Hills Biotechnology, the innovative biotech company based in Vienna, has started the New Year by embarking on the first clinical phase II study for the seasonal vaccine deltaFLU. The study will be carried out at the Medical University of Vienna. With this step, AVIR Green Hills has set yet another important milestone in the development of effective and modern influenza vaccines.

18 Jan 2010

State budgets in straits as health programs sap resources

States are grappling with budget crises and lost revenues that have affected health programs.

18 Jan 2010

Role of H. pylori in autoimmune atrophic gastritis

Experimental animal studies have shown that H. pylori shares several antigenic regions in common with acid secreting cells in gastric mucosa. Antibodies triggered by H. pylori destroy acid secreting cells due to this antigenic mimicry.

17 Jan 2010

AMGA reports significant growth in 2009; 2010 paves way for another successful year

The American Medical Group Association (AMGA) announced significant growth in 2009, during which it added 40 new member groups, representing more than 9,700 physicians treating 11 million patients.

17 Jan 2010

Results from Bionovo's phase 1B clinical trial of Bezielle published

Bionovo, Inc. announced today the publication of their results from its phase 1B clinical trial of Bezielle (BZL101) for metastatic breast cancer. The results of the study are available online in Breast Cancer Research and Treatment and demonstrate that Bezielle continues to be safe and well tolerated with clinical evidence of anticancer activity in a heavily pretreated population of women diagnosed with metastatic breast cancer.

17 Jan 2010

Boston Scientific commences patient enrollment in its WallFlex Biliary RX Fully Covered Stent trial

Boston Scientific Corporation today announced that the first patient has been enrolled in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures. This multi-center, prospective study plans to enroll 187 patients at 11 centers worldwide over the next 18 months.

17 Jan 2010

CT-guided biopsy: An alternative method for patients with pancreatic masses

It is reasonable to obtain a histological diagnosis before treating patients who have pancreatic masses and are unsuitable or unwilling to undergo surgery. As the pancreas is a deep seated organ surrounded by other vital structures, it is a challenge for the physician to obtain an adequate specimen for histological examination.

17 Jan 2010

Studies show treatment success for chronic hepatitis C may be predicted by rapid virological response

The likelihood of treatment success of 48 wk peg-interferon (PEG-IFN) plus ribavirin (RBV) therapy for chronic hepatitis C may be predicted by viral kinetics on therapy. In particular, recent studies have shown that sustained virological response (SVR) can be predicted by a rapid virological response (RVR), and an early virological response (EVR).

17 Jan 2010

Early immune response needed for 'hit-and-hide' cancer viruses

Retroviruses such as HIV and HTLV-1 don't hit-and-run, they hit-and-hide. They slip into host cells and insert their own DNA into the cell's DNA, and from this refuge they establish an infection that lasts a lifetime.

14 Jan 2010

Art program gives a ray of hope for patients

To visit Erica Arcia in the Bone Marrow Transplant unit, you first have to don a sterile gown and mask. Then you step through one door, making sure that it seals behind you. Step through the second door of the isolation room and you’re standing at Arcia’s bedside.

13 Jan 2010

Cardiac Science and MEDENT announce new partnership deal

Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices that connect to electronic medical record (EMR) and hospital information systems, today announced a partnership with MEDENT, a leading provider of practice automation and EMR/EHR systems.

13 Jan 2010

Shionogi receives approval to develop and commercialize intravenous peramivir in Japan

BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has received marketing and manufacturing approval for intravenous (i.v.) peramivir to treat patients with influenza in Japan.

13 Jan 2010

MedPro Safety Products to acquire product development rights for passive safety intravenous catheter

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, has agreed to acquire product development rights for a unique, fully passive safety intravenous catheter from a company owned by Hooman Asbaghi and Don Millerd.

13 Jan 2010

Era of rapid expansion in biomedical research funding began in 1990's ends

After a decade of remarkable growth, total annual funding for biomedical research in the U.S. has decelerated and may have even fallen when adjusted for inflation. That is the conclusion of a study today published in the Journal of the American Medical Association.

13 Jan 2010

NCCN to present recommendations on REMS in cancer care at Oncology Summit

Risk evaluation and mitigation strategies (REMS), which can be required by the FDA for drugs or biologics with significant toxicity and/or risks, are emerging as a priority topic for a variety of individuals. The goal of REMS to mitigate known or potential drug risks must be balanced with concerns that such programs may be overly complex and burdensome to physicians and other healthcare providers.

13 Jan 2010

Telecare Corporation, Eisenhower Medical Center partner to manage a new inpatient geropyschiatric program

Telecare Corporation announced today that it has partnered with Eisenhower Medical Center to manage a new inpatient geropyschiatric program. Eisenhower is a 313-bed hospital serving the Palm Springs/Rancho Mirage and greater Coachella Valley area of California.

13 Jan 2010

SOC announces ongoing expansion of emergency neurology on-call services throughout Georgia

Specialists On Call, Inc. (SOC), the nation's leading private teleneurology company, announced today that its ongoing expansion will include increasing access to emergency neurology on-call services throughout the state of Georgia.

13 Jan 2010

Hospital News and Research

Cerus' INTERCEPT platelets therapeutically effective even after seven days of storage

Results show neoadjuvant chemoradiotherapy improves patients with EC

Scientists discover new links between inherited blindness and AHI1 gene

AVIR Green Hills Biotechnology commences deltaFLU Phase II study

State budgets in straits as health programs sap resources

Role of H. pylori in autoimmune atrophic gastritis

AMGA reports significant growth in 2009; 2010 paves way for another successful year

Results from Bionovo's phase 1B clinical trial of Bezielle published

Boston Scientific commences patient enrollment in its WallFlex Biliary RX Fully Covered Stent trial

CT-guided biopsy: An alternative method for patients with pancreatic masses

Studies show treatment success for chronic hepatitis C may be predicted by rapid virological response

Early immune response needed for 'hit-and-hide' cancer viruses

Art program gives a ray of hope for patients

Cardiac Science and MEDENT announce new partnership deal

Shionogi receives approval to develop and commercialize intravenous peramivir in Japan

MedPro Safety Products to acquire product development rights for passive safety intravenous catheter

Era of rapid expansion in biomedical research funding began in 1990's ends

NCCN to present recommendations on REMS in cancer care at Oncology Summit

Telecare Corporation, Eisenhower Medical Center partner to manage a new inpatient geropyschiatric program

SOC announces ongoing expansion of emergency neurology on-call services throughout Georgia

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News